[1]
A. K. Paudel, S. Bastakoti, N. R. Dulal, G. . Piya, and S. B. Singh, “Role of Natalizumab in Relapsing-Remitting Multiple Sclerosis: A review”, J. Brain Spine Fdn Nep., vol. 2, no. 1, pp. 2–12, Aug. 2021.